跳至主要内容
临床试验/NCT05349812
NCT05349812撤回不适用

An Observational Study of Cxbladder Performance for Detection or Rule-out of Upper Tract Urothelial Cancer

Pacific Edge Limited0 个研究点开始时间: 2022年11月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Performance of Cxbladder for the detection of Upper Tract Urothelial Carcinoma (UTUC)

研究概览

简要总结

An observational study of Cxbladder performance for detection or rule-out of upper tract urothelial cancer. Subjects will be prospectively recruited to a single arm observational study to validate the performance characteristics of Cxbladder for suspected (UTUC) or for patients with a history of UTUC and are under surveillance for recurrence of disease.

详细描述

This is a single arm observational study prospectively recruiting eligible subjects with no apparent UC of the bladder following white light cystoscopy who have positive or suspicious urine cytology or imaging results.

Participants will undergo all clinical investigations as prescribed by the physician as per standard of care with addition of urine sampling to enable Cxbladder and central urine cytology testing. A mid-stream voided urine sample collected at the time of appointment will be used for Cxbladder and central urine cytology testing. Cxbladder and central cytology results will not be reported to the physician.

Urine sample testing will occur at Pacific Edge Ltd laboratories (Dunedin, New Zealand). Central urine cytology will be processed by an independent testing laboratory (Southern Community Laboratories, Dunedin, New Zealand). The remainder of the urine sample will be used for dipstick analysis of Specific Gravity, Leucocytes, Nitrites, Blood, Haemoglobin, and pH. The unused portion of this sample will be used for local cytology and any other analysis as deemed clinically appropriate. Central urine cytology results are not available to physicians.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Suspected to have UTUC following negative cystoscopy but positive or suspicious imaging and/or urine cytology.
  • Under surveillance for UTUC following a previous confirmed diagnosis of UTUC
  • Able to provide a voided urine sample of the required 30 ml minimum volume
  • Able to give written consent
  • Able and willing to comply with study requirement
  • Aged 18 years or older

排除标准

  • Prior genitourinary manipulation (flexible or rigid cystoscopy / catheterisation, urethral dilation) in the 14 days before urine collection
  • Total cystectomy of the bladder with bowel urinary diversion

结局指标

主要结局

Performance of Cxbladder for the detection of Upper Tract Urothelial Carcinoma (UTUC)

时间窗: Up to 36 months

The number of subjects identified with UTUC by Cxbladder testing as verified by the gold standard for clinical diagnosis.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Detection of Disease in the Upper Tract | 临床试验